Thyroid Hormone Interactions in Parkinson's Disease
Summary
Thyroid hormones play a multifaceted role in the central nervous system and have emerged as important modulators of dopaminergic integrity in Parkinson’s disease. The active hormone triiodothyronine (T3) and its prohormone thyroxine (T4) regulate neuronal differentiation, metabolism and synaptic plasticity via binding to nuclear receptors, including NURR1, which is critical for the development and maintenance of dopamine-producing neurons. Dysregulation of the hypothalamic–pituitary–thyroid axis has been observed in patients with Parkinson’s disease, where subtle shifts towards hypo- or hyperthyroid states can exacerbate motor symptoms, impact tremor severity and influence responses to dopaminergic therapies. Preclinical work demonstrates that controlled application of thyroid hormones can enhance survival of nigral neurons under oxidative or proteotoxic stress, while clinical case reports highlight reversible tremor exaggeration in hyperthyroid states. Genetic investigations exploring shared variants between thyroid dysfunction and Parkinson’s disease point to complex bidirectional interactions without clear common loci, suggesting that alterations in thyroid status may both reflect and modulate disease progression. These findings underscore the promise of targeted thyroid hormone derivatives or hypothalamic releasing-hormone analogues as adjunctive neuroprotective strategies, balanced against the risk of systemic endocrine disturbance. Future research demands well-powered clinical trials to define optimal dosing windows and to explore individual susceptibility conferred by endocrine and dopaminergic genotypes.
Research from Nature Portfolio
Recent studies have shown that low-concentration serum conditions can induce dopaminergic differentiation of neural precursor cells through up-regulation of NURR1. Investigators identified T3 and T4 as key drivers of this effect and developed synthetic thyroid hormone derivatives that partially activate thyroid hormone receptors. Two novel compounds promoted full maturation of dopamine neurons in vitro and provided robust protection against neurotoxic insults without eliciting excessive thyroid receptor stimulation. These derivatives demonstrate potential as disease-modifying agents by enhancing neuronal resilience while minimising systemic endocrine side effects.
Thyroid Hormone Interactions in Parkinson's Disease publication trend
The graph below shows the total number of articles in thyroid hormone interactions in parkinson's disease across all publications each year (not limited to Nature Index journals).
Technical terms
Triiodothyronine (T3): The active form of thyroid hormone that regulates gene expression and neuronal differentiation.
Thyroxine (T4): The circulating prohormone converted into triiodothyronine, influencing metabolic and neuronal processes.
Triiodothyronine-releasing hormone (TRH): A hypothalamic peptide that stimulates thyroid-stimulating hormone release and modulates neurotransmission.
Dopaminergic neuron: A nerve cell that synthesises and releases dopamine, primarily affected in Parkinson’s disease.
Mendelian randomisation: A genetic method using inheritance patterns to infer causal relationships between risk factors and disease.
References
- The potential protective role of Parkinson’s disease against hypothyroidism: co-localisation and bidirectional Mendelian randomization study. Frontiers in Aging Neuroscience (2024).
- Dopamine neuron induction and the neuroprotective effects of thyroid hormone derivatives. Scientific Reports (2019).
- TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone. Frontiers in Cellular Neuroscience (2018).
- AMI, an Indazole Derivative, Improves Parkinson’s Disease by Inhibiting Tau Phosphorylation. Frontiers in Molecular Neuroscience (2020).
- Thyroid‐Induced Worsening of Parkinsonian Tremor Resistant to Drugs and Subthalamic Nucleus Deep Brain Stimulation. Case Reports in Neurological Medicine (2014).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.